Company performance
Add to research
Current Price
as of Jun 13, 2025$83.97
P/E Ratio
19.60
Market Cap
$4.15B
Description
Add to research
Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the North American OTC Healthcare and International OTC Healthcare segments. The North American OTC Healthcare segment consists of BC and Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve. The International OTC Healthcare segment includes Fess and Hydralite. The company was founded in 1996 and is headquartered in Tarrytown, NY.
Metrics
Add to research
Overview
- HQTarrytown, NY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerPBH
- Price$83.97-1.37%
Trading Information
- Market cap$4.15B
- Float98.69%
- Average Daily Volume (1m)306,675
- Average Daily Volume (3m)364,360
- EPS$4.32
Company
- Revenue$1.14B
- Rev growth (1yr)1.10%
- Net income$214.61M
- Gross margin53.89%
- EBITDA margin33.35%
- EBITDA$379.41M
- EV$5.25B
- EV/Revenue4.62
- P/E19.60
- P/S3.70
- P/B2.27
- Debt/Equity56.91
Documents
Add to research
SEC Filings
Earnings Calls